Life Sciences

News

Medicxi co-founder and partner Francesco De Rubertis

Medicxi primes its latest $400m biotech fund

Anglo-Swiss life sciences investment company Medicxi has raised $400 million for its fourth fund, which will focus on supporting 'asset-centric' companies at all stages of

News

London’s life sciences skyscraper gets planning consent

Plans for a major life sciences development at Canary Wharf in London, UK, have been approved by the local authorities, allowing the project to go ahead.

R&D

The 4 must-have characteristics for finding the right patien...

The life sciences community is a powerful force determined to bring hope and healing to people around the world through relentless research and exploration.

Sales & Marketing

12 Questions with Chih Han Chen

Chih Han Chen is a distinguished leader with a strong footing in data science and AI for the life sciences sector.

Sales & Marketing

Life sciences must reinvent the commercial model to keep pac...

The past five years have witnessed extraordinary progress in life sciences, marked by unprecedented innovation and achievements.

Sales & Marketing

NHS-life sciences partnership: Learning and recovering from ...

In a recent IQVIA webinar, ‘Partnering with the NHS in a crisis’, representative experts from the life sciences industry and the NHS explored why collaboration between the two is more criti

Medicxi primes its latest $400m biotech fund

London’s life sciences skyscraper gets planning consent

The 4 must-have characteristics for finding the right patien...

12 Questions with Chih Han Chen

Life sciences must reinvent the commercial model to keep pac...

NHS-life sciences partnership: Learning and recovering from ...

Remepy's hybrid Parkinson's therapy poised for phase 3

Discover a new era of healthcare panel engagement: Grounded ...

Life Sciences

Editor's Picks